User profiles for "author:A. Gupta"

Abhinav Gupta

- Verified email at cs.cmu.edu - Cited by 68914

Anil K. Gupta

- Verified email at umd.edu - Cited by 41360

Anjali Gupta

- Verified email at chiwest.com - Cited by 6134

[HTML][HTML] Extrapulmonary manifestations of COVID-19

A Gupta, MV Madhavan, K Sehgal, N Nair… - Nature medicine, 2020 - nature.com
Although COVID-19 is most well known for causing substantial respiratory pathology, it can
also result in several extrapulmonary manifestations. These conditions include thrombotic …

[HTML][HTML] Post-acute COVID-19 syndrome

A Nalbandian, K Sehgal, A Gupta, MV Madhavan… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications

AK Gupta, M Gupta - biomaterials, 2005 - Elsevier
Superparamagnetic iron oxide nanoparticles (SPION) with appropriate surface chemistry
have been widely used experimentally for numerous in vivo applications such as magnetic …

Experimental and theoretical challenges in the search for the quark–gluon plasma: The STAR Collaboration's critical assessment of the evidence from RHIC collisions

…, D Grosnick, SM Guertin, Y Guo, A Gupta… - Nuclear Physics A, 2005 - Elsevier
We review the most important experimental results from the first three years of nucleus–
nucleus collision studies at RHIC, with emphasis on results from the STAR experiment, and …

[HTML][HTML] Safety, activity, and immune correlates of anti–PD-1 antibody in cancer

…, D McDonald, GD Kollia, A Gupta… - … England Journal of …, 2012 - Mass Medical Soc
Background Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T
cells, can overcome immune resistance. We assessed the antitumor activity and safety of …

[HTML][HTML] Nivolumab plus ipilimumab in advanced melanoma

…, AJ Korman, JM Wigginton, A Gupta… - … England Journal of …, 2013 - Mass Medical Soc
Background In patients with melanoma, ipilimumab (an antibody against cytotoxic T-
lymphocyte–associated antigen 4 [CTLA-4]) prolongs overall survival, and nivolumab (an …

Beyond the imitation game: Quantifying and extrapolating the capabilities of language models

…, A Abid, A Fisch, AR Brown, A Santoro, A Gupta… - arXiv preprint arXiv …, 2022 - arxiv.org
Language models demonstrate both quantitative improvement and new qualitative
capabilities with increasing scale. Despite their potentially transformative impact, these new …

[HTML][HTML] Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab

A Gupta, Y Gonzalez-Rojas, E Juarez… - … England Journal of …, 2021 - Mass Medical Soc
Abstract Background Coronavirus disease 2019 (Covid-19) disproportionately results in
hospitalization or death in older patients and those with underlying conditions. Sotrovimab is …

[HTML][HTML] Safety and activity of anti–PD-L1 antibody in patients with advanced cancer

…, SM Goldberg, DM Pardoll, A Gupta… - … England Journal of …, 2012 - Mass Medical Soc
Background Programmed death 1 (PD-1) protein, a T-cell coinhibitory receptor, and one of
its ligands, PD-L1, play a pivotal role in the ability of tumor cells to evade the host's immune …

[HTML][HTML] Multisystem inflammatory syndrome in US children and adolescents

…, KN Clouser, JS Giuliano Jr, A Gupta… - … England Journal of …, 2020 - Mass Medical Soc
Background Understanding the epidemiology and clinical course of multisystem
inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus …